101 related articles for article (PubMed ID: 25518581)
1. [Carcinoembryonic antigen as a marker of proliferative diseases of the lymphatic system in patients with chronic renal failure--case report].
Janas M; Niemczyk S; Mazur S
Pol Merkur Lekarski; 2014 Oct; 37(220):237-9. PubMed ID: 25518581
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment.
Cetinkaya R; Odabas AR; Selcuk Y; Erman Z; Kaya H
South Med J; 2003 May; 96(5):491-3. PubMed ID: 12911189
[TBL] [Abstract][Full Text] [Related]
3. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
Salim KA; Salim S; Mathew T
J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
[TBL] [Abstract][Full Text] [Related]
4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
5. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
6. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
[TBL] [Abstract][Full Text] [Related]
7. [Clinical relevance of anemia treatment in patients with chronic kidney disease].
Vuksanović-Mikulicić S; Mikolasević I; Jelić I; Bubić I; Sladoje-Martinović B; Racki S
Acta Med Croatica; 2012 Jul; 66(3):193-202. PubMed ID: 23441533
[TBL] [Abstract][Full Text] [Related]
8. [Anemia in chronic renal insufficiency--case report].
Popović M
Med Pregl; 1999; 52(6-8):279-81. PubMed ID: 10518388
[TBL] [Abstract][Full Text] [Related]
9. Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease.
Foley RN
Rev Cardiovasc Med; 2005; 6 Suppl 3():S27-34. PubMed ID: 16340936
[TBL] [Abstract][Full Text] [Related]
10. [Management of renal anemia in 2013].
Gianella P; Martin PY; Stucker F
Rev Med Suisse; 2013 Feb; 9(375):462-4, 466-7. PubMed ID: 23539813
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of renal anemia.
Eckardt KU
Clin Nephrol; 2000 Feb; 53(1 Suppl):S2-8. PubMed ID: 10746799
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
15. Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.
Guerrero-Riscos MÁ; Montes-Delgado R; Seda-Guzmán M; Praena-Fernández JM
Nefrologia; 2012 May; 32(3):343-52. PubMed ID: 22535158
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
17. [Erythropoietin: from established therapeutic procedures in renal anemia to future areas of use].
Marsen TA; Pollok M; Baldamus CA
Med Klin (Munich); 1992 Apr; 87(4):207-14. PubMed ID: 1579099
[No Abstract] [Full Text] [Related]
18. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
Artunc F; Risler T
Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
[TBL] [Abstract][Full Text] [Related]
19. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
[TBL] [Abstract][Full Text] [Related]
20. [Chronic kidney failure, anemia and erythropoietin].
Sulková S
Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
